Over 150 scientific sessions will be presented during the congress, focusing on advancements in environmental science, food allergies, innovations in immunotherapy, and pediatric allergies, among others. Precision medicine, AI, ...
Read MoreApril 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4% Comparable order intake -3.8%, mainly due to China USD 1.1 billion Respironics litigation settlement reached in the US ...
Read MorePORTSMOUTH, N.H. , April 30, 2024 /PRNewswire/ -- Laborie Medical Technologies Corp. (Laborie), a leading diagnostic and therapeutic medical technology company, welcomed the inclusion of Optilume ® Urethral Drug-Coated Balloon (DCB) into ...
Read MoreTAIPEI , April 30, 2024 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP-020 in Australia . The Phase 1 clinical trial is a ...
Read MoreZimmerman Reed announces $7 million settlement for the U.S. and State of California in a first-of-its kind False Claims Act case involving a COVID-19 waiver program. MINNEAPOLIS, Minn. , April 29, 2024 /PRNewswire-PRWeb/ -- ...
Read MoreA national consortium based at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was awarded $17 million by the U.S. Department of Defense for new research in traumatic brain injury and psychological ...
Read MorePITTSBURGH , April 29, 2024 /PRNewswire/ -- PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, today announced it was selected by X4 Pharmaceuticals, Inc. for the distribution of ...
Read MoreUp to $1 million to develop a resource hub to support health care professionals in providing palliative care to children and families. OTTAWA, ON , April 29, 2024 /CNW/ - Everyone in Canada deserve access to the care they need, when ...
Read MoreMore than 20 million people in the U.S. are living with peripheral artery disease (PAD) yet there have been limited treatment options The first-of-its-kind Esprit™ BTK Everolimus Eluting Resorbable Scaffold dissolves over time after it has ...
Read MorePure Arctic Cod Oil at Low Oxidation Levels Neutralize That Infamous Fishy Flavor, Turning Arctic Blue's Oils Into a Palatable, Ultra-Nutritious Supplement for the Whole Family FORT LAUDERDALE, Fla. , April 29, 2024 /PRNewswire/ -- Fish ...
Read MorePalliative Care Is a Comprehensive Approach to Long-Term Patient Care. Caregivers Can Use Cinesteam®'s Secondary Dressings to Improve Quality of Life in Palliative Care Settings. FORT LAUDERDALE, Fla. , April 29, 2024 /PRNewswire/ ...
Read MoreNutricog ® Cognitive Performance Complex has been Clinically Demonstrated to Improve Memory, Increase Learning Rate and Capacity, Enhance Focus and Concentration and Improve Overall Brain Function MORRISTOWN, N.J. , April 29, 2024 ...
Read MoreCHENGDU, China , April 29, 2024 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report the Company has begun dosing patients in its Phase 2a clinical trial (NCT06363461) ...
Read MoreCanada demonstrates global leadership in work to reduce smoking OTTAWA, ON , April 29, 2024 /CNW/ - Canada's world precedent-setting requirement for warnings directly on every individual cigarette is now being implemented with these ...
Read MoreLONDON , April 29, 2024 /PRNewswire/ -- Huma Therapeutics ("Huma"), a leader in global digital health innovation, together with Merck KGaA, Darmstadt, Germany , a leading science and technology company, today announced the launch of their ...
Read MoreTAIPEI , April 29, 2024 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576) ("Foresee") announced today that it will actively participate in and present two posters at the 2024 American Thoracic Society (ATS) International Conference, ...
Read MoreThe Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thrivers. This year we will be hosting ...
Read MoreOTTAWA, ON , April 26, 2024 /CNW/ - Summary Product: Counterfeit Viagra, 100 mg sildenafil tablets Issue: Health products - Product safety, Unauthorized product What to do: Immediately stop using and safely dispose of this ...
Read MoreRecord sales in April accelerating the pathway to profitability New IP will lead the way in changing the way migraine headaches are addressed WEST PALM BEACH, Fla. , April 26, 2024 /PRNewswire/ -- eNeura, a pioneering leader in ...
Read MoreThis program will support individuals in Putnam County with Opioid Use Disorder and co-occurring substance use and mental health conditions through peer support and harm reduction for the broader Putnam County community. POUGHKEEPSIE, N.Y. ...
Read MoreSUZHOU, China , April 26, 2024 /PRNewswire/ -- Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's ...
Read MoreThe second DMC review recommends the continuation of dose escalation in the clinical trial as per protocol. The interim safety assessment was based on the review of safety data from 18 metastatic gastrointestinal cancer patients, including ...
Read MoreKYOTO, Japan , April 26, 2024 /PRNewswire/ -- OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture , Japan , announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure ...
Read MorePlanning enters next phase as ABMS announces open comment period WASHINGTON , April 25, 2024 /PRNewswire/ -- Efforts by the American College of Cardiology, the American Heart Association, the Heart Failure Society of America, the Heart ...
Read MoreSTATEN ISLAND, N.Y. , April 25, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial ...
Read MoreSHANGHAI , April 25, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase I/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 ...
Read MoreNighttime Coughing Data From More Than One Million Daily Active Users Provides Detailed Coughing Maps, Trends and Comparisons GOTHENBURG, Sweden , April 25, 2024 /PRNewswire-PRWeb/ -- Sleep Cycle , a global leader in AI-driven sleep ...
Read MoreThe North Carolina -based study will continue to test enrolled newborns for hundreds of childhood-onset rare genetic conditions RESEARCH TRIANGLE PARK, N.C. and WALTHAM, Mass. , April 25, 2024 /PRNewswire/ -- RTI International today ...
Read MoreHOLON, Israel , April 25, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE:CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that it will present new ...
Read MoreParas Healthcare Private Limited performed Bhumi Pujan for its proposed 300 bed Hospital in GurugramGurugram 25th April 2024: Paras Healthcare Private Limited (“Paras Health”) a corporate hospital chain which launched its first hospital in Gurugram ...
Read MoreWorld pulmonary hypertension community to unite on May 5 to raise awareness, offer support and advocate for PH. WASHINGTON , April 24, 2024 /PRNewswire-PRWeb/ -- The Pulmonary Hypertension Association will unite with over 80 ...
Read MoreV-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investors Oncode Oncology Bridge Fund, Swanbridge and BOM Flindr ...
Read MoreSubscribe to our Free Newsletters!